Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Eph Receptor A2 ELISA Kit (AC2719)
Cat.#: ASET-1308
Specifications
Description Human Eph Receptor A2 ELISA Kit allows for the in vitro quantitative determination of human Eph Receptor A2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1411 Human Plexin B1 ELISA Kit (AC2822) Quantitative inquiry ASET-2439 Human PON3 ELISA Kit (AC3850) Quantitative inquiry ASET-2291 Human Wnt5a ELISA Kit (AC3702) Quantitative inquiry ASET-2067 Rat GMFB ELISA Kit (AC3478) Quantitative inquiry ASET-1353 Human Eph Receptor A3 ELISA Kit (AC2764) Quantitative inquiry ASET-2314 Human TNF Receptor II ELISA Kit (AC3725) Quantitative inquiry ASET-1572 Human Adenosine A1 Receptor ELISA Kit (AC2983) Quantitative inquiry ASET-1726 Mouse PACAP ELISA Kit (AC3137) Quantitative inquiry ASET-2269 Human GDF6 ELISA Kit (AC3680) Quantitative inquiry ASET-1518 Human Optineurin ELISA Kit (AC2929) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket